We are pleased to announce that as of October 1, 2018, Aetna — a Fortune 500 Company that has been described by the New York Times as “one of the most progressive actors
in corporate America” — has accepted Acutis as a national, in-network provider.  


Acutis maintains its commitment to its clients and the industry with:

  1. A no-compromise work ethic that adheres to protocols that have no tolerance for error. 

  2. Our proprietary 728 Patient Report™ that enables clinical decisions by pointing out abuse
    of prescription/illicit drugs that are too often missed by providers.

  3. A sense of urgency — 97% of our reports are delivered by the next business day.

  4. A payor-centric approach that believes good healthcare delivered
    at the lowest cost is a business imperative. 

  5. An adherence to “medical necessity” as the only basis for testing,
    which leads to better patient outcomes with minimal testing.

Only a few, select clinical toxicology laboratories have been accepted as Aetna in-network providers. We see our acceptance as an affirmation, not only for Acutis as a whole, but of every single member of our company, from our PhDs to our support staff. We are honored to have earned Aetna’s trust and will work hard and smart to keep it.

“We will continue to refine our science and technology to ensure greater accuracy and consistency, as well as regular cost savings and rapid turn-around time.
What’s more, our ongoing investment in research and development will lead to greater advancements in clinical toxicology, as well as state-of-the-art diagnostic tests in infectious disease and molecular diagnostics.”
— Jibreel Sarij, Acutis’ CEO

Click, act & go



Sign in to view your patients' results and order new tests. 


Make a payment

 I am paying on behalf of a patient or a practice.


Arrange a sample pick-up

Our internal systems ensure accurate
and timely pick-up of samples. 

Order supplies

 Our logistics specialists see that materials are
shipped exactly where and when you need them.   


Our specialties


A corporate culture that
will not compromise or tolerate error.


Tests and systems that detect prescription drug abuse and misuse. 

& addiction detection

Innovative practices and procedures that quickly deliver critical information. 


Acutis’ first Autumn Symposium
a success

On October 23, Acutis held its first Autumn Symposium, a dinner featuring Dr. Jeffrey Fudin, PharmD,
the renowned clinical pharmacy specialist, opioid risk management specialist. Dr. Fudin spoke on topics related to treatment of substance abuse & addiction, emphasizing Urine Drug Monitoring, to an audience
of almost 20 physicians, clinicians and pharmacists. Read more…

News & insights

Acutis is on it. This November, Acutis was on hand at the 2018 New York & New Jersey Societies of Interventional Pain Physicians’ Pain Medicine Symposium (NY/NJSIPP) at the Hyatt Regency, Jersey City, New Jersey.
Read more…